Rules Based Medicine Obtains $25,000,000 Series A Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d8945cd2-e668-4f44-aa92-0f6ae29bc277&Preview=1
Date 10/15/2007
Company Name Rules Based Medicine
Mailing Address 3300 Duval Road Austin, TX 78759
Company Description Rules-Based Medicine (RBM), the world’s leading multiplexed biomarker testing company, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform. RBM’s biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species.
Proceeds Purposes The financing will provide growth capital, debt repayment, and funding for acquisitions and investments to discover and validate biomarkers for medical diagnostics.